Scientists Concerned Latest Gene Editing of Human Embryos Could "Open the Floodgates"
Futurism • • business
Key Points:
- A team led by Columbia University geneticist Dieter Egli used base editing, a technique that edits a single DNA strand, to modify two genomic sites in human embryos, aiming to demonstrate a safer alternative to CRISPR without intending therapeutic applications.
- Despite the embryos not being carried to term, the research has reignited ethical debates, with experts warning it could open the door to controversial embryo enhancements and violate informal research agreements due to the lack of strict regulatory oversight in the US.
- The study revealed issues such as mosaicism, where genetically different cells exist within the same embryo, posing potential medical risks if developed into a baby, highlighting the current limitations and risks of gene editing in embryos.
- Supporters of the research see it as a step toward future disease prevention, while critics argue it provides a blueprint for ethically questionable genetic modifications, emphasizing the ongoing controversy surrounding human embryo gene editing.
